Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

147205 Press Releases
DateTitleCompany
08 Dec 16 Novartis' Ultibro® Breezhaler® improved lung function and COPD symptoms after direct switch from previous treatment Published by
GlobeNewswire
08 Dec 16 Nexstim Plc's Financial Information in 2017 Published by
GlobeNewswire
08 Dec 16 Mithra Pharmaceuticals: SUCCESS FOR MYRING EUROPEAN CLINICAL TRIAL Mithra Pharmaceuticals,
Published by
GlobeNewswire
08 Dec 16 Novartis' Ultibro® Breezhaler® improved lung function and COPD symptoms after direct switch from previous treatment Novartis International AG,
Published by
GlobeNewswire
08 Dec 16 Sanofi and Regeneron Announce Marketing Authorization Application for Dupixent® (dupilumab) Accepted for Review by the EMA Sanofi,
Published by
GlobeNewswire
08 Dec 16 Probiodrug: Innovative Phase II study design of Glutaminylcyclase Inhibitor PQ912 in early Alzheimer's disease Probiodrug,
Published by
GlobeNewswire
08 Dec 16 Nexstim Plc's Financial Information in 2017 Nexstim Oyj,
Published by
GlobeNewswire
08 Dec 16 Biohaven Announces Orphan Drug Designation Request Granted For BHV-0223 In The Treatment Of Amyotrophic Lateral Sclerosis ("ALS") Biohaven Pharmaceutical Holding Company Ltd.,
Published by
PR Newswire
08 Dec 16 Heptares Scientists Solve Structure of CCR9 Chemokine Receptor Offering Unique Opportunity to Apply Structure-Based Design Across Chemokine Receptor Family Heptares Therapeutics,
Published by
PR Newswire
08 Dec 16 Medicrea to Host Key Opinion Leader Breakfast in New York City for Investors Focused on Advances in the Personalized Spine Market The MEDICREA Group,
Published by
Business Wire
08 Dec 16 Sanofi and Regeneron Announce Marketing Authorization Application for Dupixent® (dupilumab) Accepted for Review by the EMA Published by
GlobeNewswire
08 Dec 16 Probiodrug: Innovative Phase II study design of Glutaminylcyclase Inhibitor PQ912 in early Alzheimer's disease Published by
GlobeNewswire
08 Dec 16 Regeneron and Sanofi Announce Marketing Authorization Application for Dupixent® (dupilumab) Accepted for Review by the EMA Regeneron Pharmaceuticals, Inc.,
Published by
PR Newswire
08 Dec 16 Astellas Research & Development Meeting Highlights Astellas Pharma Inc.,
Published by
Business Wire
08 Dec 16 Puma Biotechnology Presents Interim Results of Phase II Trial of PB272 for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2016 San Antonio Breast Cancer Symposium Puma Biotechnology, Inc.,
Published by
Business Wire
08 Dec 16 Puma Biotechnology Presents Results of Biomarker Analysis of Phase II Trial of PB272 in Neoadjuvant Treatment of HER2-Positive Locally Advanced Breast Cancer at the 2016 San Antonio Breast Cancer Symposium Puma Biotechnology, Inc.,
Published by
Business Wire
08 Dec 16 Panasonic Healthcare to Sponsor Panel on Cell Expansion Considerations at 2016 World Stem Cell Summit Panasonic Healthcare Corporation of North America,
Published by
Business Wire
07 Dec 16 Argos Therapeutics Reports Highlights from Investor Day in New York City Published by
GlobeNewswire
07 Dec 16 Ohr Pharmaceutical Announces Proposed Public Offering of Common Stock and Warrants Published by
GlobeNewswire
07 Dec 16 Clearside Biomedical, Inc. Announces Proposed Offering of Common Stock Published by
GlobeNewswire
07 Dec 16 The Joint Corp. Tops Single Day System-Wide Sales Record Published by
GlobeNewswire
07 Dec 16 Visioneering Technologies, Inc. Announces Ms. Rosa Lee as New Executive Director of Manufacturing & Engineering Visioneering Technologies, Inc. (VTI),
Published by
Business Wire
07 Dec 16 Global Drug Delivery Technologies - What Are the Various Advantages, Limitations & Applications of the Currently Available Drug Carriers? - Research and Markets Research and Markets,
Published by
Business Wire
07 Dec 16 Global E-Clinical Solution Market - High Cost of Implementation & Long Approval Time for Clinical Trials are Key Challenges - Research and Markets Research and Markets,
Published by
Business Wire
07 Dec 16 LeMaitre Vascular to Participate in the Guggenheim Securities 4th Annual Boston Healthcare Conference on Tuesday, December 13, 2016 Published by
GlobeNewswire
07 Dec 16 Integra LifeSciences to Host Regenerative Technology Investor Day and Webcast Wednesday, December 14, 2016 Published by
GlobeNewswire
07 Dec 16 Palatin Technologies Closes on $16.5 Million Financing Palatin Technologies, Inc.,
Published by
PR Newswire
07 Dec 16 ACRO Applauds Passage of 21st Century Cures Act Association of Clinical Research Organizations (ACRO),
Published by
Business Wire
07 Dec 16 Baxter to Present at the 35th Annual J.P. Morgan Healthcare Conference Baxter International Inc.,
Published by
Business Wire
07 Dec 16 Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results Arrowhead Pharmaceuticals, Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.